Art Photonics Sponsors EPIC Meeting on Photonics Assisted Cancer Pathology and Surgery at University Hospital Antwerp We are thrilled to announce our sponsorship of the upcoming EPIC Meeting on Photonics Assisted Cancer Pathology and Surgery, scheduled for November 29-30, 2023, at the University Hospital Antwerp in Belgium. At art photonics, we are dedicated to exploring […]
Our CEO & President, Viacheslav Artyushenko, recently delivered an insightful presentation at the BioPhotonics Conference 2023. Explore the transformative impact of Fiber Solutions on specialized Biomedical Applications! Catch the webinar titled "Fiber Solutions in 0.3 to 16µm Range Enable Specialized Biomedical Applications" here! We extend our gratitude to Photonics Media for their support in showcasing […]
Join us at the EPIC Food & Beverage Online Technology Meeting! 🥂 Embrace the Future of Photonics in Food Processing 🔬✨ We are thrilled to invite you to the EPIC Online Technology Meeting on Food and Beverages, where we will explore how photonics can revolutionize remote process control and enhance quality assurance in the food […]
Join us at the EPIC Online Technology Meeting on New Mid-IR Developments for Novel Industrial Manufacturing, taking place on November 20, 2023, from 15:00 to 17:00 CET! We are proud sponsors of this event, underscoring our commitment to driving innovation in industrial manufacturing through cutting-edge Mid-IR Spectroscopy. At art photonics, we firmly believe in the […]
art photonics GmbH, founded in Berlin in September 1998, is one of the worldwide leaders in development and production of specialty fiber products for a broad spectrum from 300 nm to 16 µm. Unique technologies of Polycrystalline Mid InfraRed (PIR-) fibers and Metal coated Silica fibers are used for assembly of various spectroscopy probes for medical diagnostics and industrial process control, in volume production of fiber for medical and industrial lasers, for different fiber bundles, etc.
Innovative “Raman – needle” fiber optic probe for tumour delineation in the oral cavity
20 March 2020
Here we report the development of a new “Raman-needle” fiber probe, which was designed and manufactured as part of the RaSure project, funded by the EU “Eurostars” program.
About RaSure project:
Oral cavity cancer is a major public health issue, with annually 300.000 new cases. Surgery is the mainstay of treatment, but adequate tumour removal is not achieved in 85% of the cases. This affects survival and leads to additional treatment of patients by radiotherapy or chemotherapy. The hands and eyes of the surgeon are insufficient for tumour delineation in the oral cavity. Significant improvement is needed to improve the surgical success rate. In frames of RaSure, a fully automated Raman spectroscopic device is under development to achieve complete tumour removal in oral cancer surgeries. The product will consist of a dedicated Raman-based tissue inspection device, the operational system and disposable fiber-optic needle probes.
The consortium, which includes three companies: art photonics GmbH, RiverD International BV and Erasmus MC was tasked to develop a fully automated Raman spectroscopic device to help surgeons achieve complete tumour removal in oral cavity cancer surgeries. The device is inspecting removed tissue to check if the tumour has been removed with a sufficient boundary of healthy tissue during the surgery. If not, the device will inform the surgeon where extra tissue should be removed to achieve complete tumour removal. The role of art photonicsGmbH is the development of the unique disposable Raman-needle fiber probe that can be inserted into the tissue multiple times and measure without loss of quality of the results.
The innovative needle probe is satisfied the strict requirements from clinicians: tiny diameter (less than 1 mm), biocompatible materials and robustness. The above-mentioned features allow Raman probe to be inserted into the tissue sample multiple times. The Raman needle probe prototypes were extensively tested together with consortium partners in Erasmus MD and in Charité Clinic in operational theatre. The prototypes on fresh resected human tongue samples are showed reliable performance in recognition of cancer and non-cancer samples. The differentiation between tumour (T) and normal (N) parts of tongue are clearly visible both on Raman spectra and on PCA models. The results are perfectly corresponding to the information received from surgeon.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions of the website.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.